TherapeuticsMD (TXMD) Announces $7M Private Placement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
TherapeuticsMD Announces $7 Million Private Placement
October 3, 2022 6:50 AM EDTMaturity Date of Financing Agreement Extended to October 31, 2022, with the Ability to Extend to November 30, 2022, if Additional Capital is Raised
BOCA RATON, Fla.--(BUSINESS WIRE)-- TherapeuticsMD, Inc. (NASDAQ: TXMD), (TherapeuticsMD or the Company) an innovative, leading womens healthcare company, announced today that it received a $7 million private investment in the Companys Series A Preferred Stock from Rubric Capital Management LP (Rubric). TherapeuticsMD expects to use the proceeds from the transaction for working capital.
Under the terms of the Companys financing agreement with its lender, Sixth Street Specialty... More
